FI102895B1 - Förfarande för framställning av terapeutiskt aktiva 5-(fenylsulfonylamino)- och 5-(fenylsulfonylaminokarbonyl)pyridin-2-karboxylsyraamider - Google Patents

Förfarande för framställning av terapeutiskt aktiva 5-(fenylsulfonylamino)- och 5-(fenylsulfonylaminokarbonyl)pyridin-2-karboxylsyraamider

Info

Publication number
FI102895B1
FI102895B1 FI931250A FI931250A FI102895B1 FI 102895 B1 FI102895 B1 FI 102895B1 FI 931250 A FI931250 A FI 931250A FI 931250 A FI931250 A FI 931250A FI 102895 B1 FI102895 B1 FI 102895B1
Authority
FI
Finland
Prior art keywords
pyridine
phenylsulfonylaminocarbonyl
phenylsulfonylamino
preparation
carboxylic acid
Prior art date
Application number
FI931250A
Other languages
English (en)
Finnish (fi)
Other versions
FI931250A0 (fi
FI931250A (fi
FI102895B (sv
Inventor
Klaus Weidmann
Martin Bickel
Volkmar Guenzler-Pukall
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI931250A0 publication Critical patent/FI931250A0/fi
Publication of FI931250A publication Critical patent/FI931250A/fi
Application granted granted Critical
Publication of FI102895B1 publication Critical patent/FI102895B1/sv
Publication of FI102895B publication Critical patent/FI102895B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI931250A 1992-03-24 1993-03-22 Förfarande för framställning av terapeutiskt aktiva 5-(fenylsulfonylam ino)- och 5-(fenylsulfonylaminokarbonyl)pyridin-2-karboxylsyraamider FI102895B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4209424 1992-03-24
DE4209424 1992-03-24
DE4238506 1992-11-14
DE4238506 1992-11-14

Publications (4)

Publication Number Publication Date
FI931250A0 FI931250A0 (fi) 1993-03-22
FI931250A FI931250A (fi) 1993-09-25
FI102895B1 true FI102895B1 (sv) 1999-03-15
FI102895B FI102895B (sv) 1999-03-15

Family

ID=25913130

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931250A FI102895B (sv) 1992-03-24 1993-03-22 Förfarande för framställning av terapeutiskt aktiva 5-(fenylsulfonylam ino)- och 5-(fenylsulfonylaminokarbonyl)pyridin-2-karboxylsyraamider

Country Status (24)

Country Link
US (1) US5607954A (sv)
EP (1) EP0562512B1 (sv)
JP (1) JPH0649030A (sv)
KR (1) KR930019630A (sv)
CN (1) CN1076691A (sv)
AT (1) ATE199250T1 (sv)
AU (1) AU657608B2 (sv)
CA (1) CA2092276A1 (sv)
CZ (1) CZ46393A3 (sv)
DE (1) DE59310146D1 (sv)
DK (1) DK0562512T3 (sv)
ES (1) ES2154266T3 (sv)
FI (1) FI102895B (sv)
GR (1) GR3035479T3 (sv)
HK (1) HK1011987A1 (sv)
HU (2) HU219224B (sv)
MY (1) MY109143A (sv)
NO (1) NO179867C (sv)
NZ (1) NZ247201A (sv)
PL (1) PL173677B1 (sv)
PT (1) PT562512E (sv)
RU (1) RU2129545C1 (sv)
SK (1) SK280884B6 (sv)
TW (1) TW352384B (sv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE149485T1 (de) * 1993-11-02 1997-03-15 Hoechst Ag Substituierte heterocyclische carbonsäureamidester, ihre herstellung und ihre verwendung als arzneimittel
ES2101421T3 (es) * 1993-11-02 1997-07-01 Hoechst Ag Amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
TW406076B (en) * 1993-12-30 2000-09-21 Hoechst Ag Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
DE4410423A1 (de) * 1994-03-25 1995-09-28 Hoechst Ag Sulfonamidocarbonylpyridin-2-carbonsäureamide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE4410453A1 (de) * 1994-03-25 1995-09-28 Hoechst Ag Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
DE4410480A1 (de) * 1994-03-25 1995-09-28 Hoechst Ag Sulfonamidocarbonylpyridin-2-carbonsäureesteramide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE4410454A1 (de) * 1994-03-25 1995-09-28 Hoechst Ag Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
IL135495A (en) * 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
DE19742951A1 (de) * 1997-09-29 1999-04-15 Hoechst Schering Agrevo Gmbh Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung
DE19746287A1 (de) * 1997-10-20 1999-04-22 Hoechst Marion Roussel De Gmbh Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
AR015733A1 (es) 1998-03-25 2001-05-16 Otsuka Pharma Co Ltd DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO.
US6583318B2 (en) 2001-05-17 2003-06-24 Advanced Syntech, Llc Method for synthesis of α-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives
EP2295060B1 (en) 2001-12-06 2018-10-31 Fibrogen, Inc. Treatment or prevention of ischemic or hypoxic conditions
DK2289531T3 (en) * 2001-12-06 2018-10-01 Fibrogen Inc Medications for the treatment or prevention of anemia
US8124582B2 (en) 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
US7618940B2 (en) * 2002-12-06 2009-11-17 Fibrogen, Inc. Fat regulation
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
WO2006138511A2 (en) 2005-06-15 2006-12-28 Fibrogen, Inc. Use of hif 1alfa modulators for treatment of cancer
KR100934671B1 (ko) * 2006-03-30 2009-12-31 엘지전자 주식회사 비디오 신호를 디코딩/인코딩하기 위한 방법 및 장치
PL3026044T3 (pl) 2006-06-26 2019-04-30 Akebia Therapeutics Inc Inhibitory prolilo-hydroksylazy i sposoby ich użycia
JP2010528035A (ja) * 2007-05-25 2010-08-19 バーテックス ファーマシューティカルズ インコーポレイテッド イオンチャネル調節物質およびその使用
WO2009002533A1 (en) * 2007-06-27 2008-12-31 The Brigham And Women's Hospital, Inc. Inflammatory bowel disease therapies
NO2686520T3 (sv) 2011-06-06 2018-03-17
JP6302846B2 (ja) 2012-02-22 2018-03-28 サンフォード−バーンハム メディカル リサーチ インスティテュート Tnap阻害剤としてのスルホンアミド化合物およびその使用
TW201512171A (zh) 2013-04-19 2015-04-01 Pfizer Ltd 化學化合物
DK3007695T3 (da) 2013-06-13 2024-03-18 Akebia Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af anæmi
JP2016537365A (ja) 2013-11-15 2016-12-01 アケビア セラピューティクス インコーポレイテッドAkebia Therapeutics Inc. {[5−(3−クロロフェニル)−3−ヒドロキシピリジン−2−カルボニル]アミノ}酢酸の固体形態、組成物、及びその使用
BR112017015852A2 (pt) 2015-01-23 2018-03-27 Akebia Therapeutics Inc forma de cristal, sal hemicálcico, sal hemicálcico di-hidratado, sal monossódico hidratado, sal bissódico monoidratado, sal monossódico anidro e método para preparar o composto 1
CN106146395B (zh) * 2015-03-27 2019-01-01 沈阳三生制药有限责任公司 3-羟基吡啶化合物、其制备方法及其制药用途
HRP20211862T1 (hr) 2015-04-01 2022-03-04 Akebia Therapeutics, Inc. Pripravci za i postupci liječenja anemije
AR114886A1 (es) 2018-05-09 2020-10-28 Akebia Therapeutics Inc Proceso para preparar ácido 2-[[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino]acético
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
CN111972405A (zh) * 2020-07-27 2020-11-24 南京太化化工有限公司 一种悬浮剂用助剂及异恶唑草酮悬浮剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432094A1 (de) * 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
DE3703962A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
US5153208A (en) * 1987-02-10 1992-10-06 Hoechst Aktiengesellschaft Pyridine-2,4- and -2,5-dicarboxylic acid amides and their medicinal compositions and methods of use
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3928144A1 (de) * 1989-08-25 1991-02-28 Hoechst Ag Zyklische pyridin-2,4- und -2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung

Also Published As

Publication number Publication date
MY109143A (en) 1996-12-31
JPH0649030A (ja) 1994-02-22
NO931056D0 (no) 1993-03-23
AU3536993A (en) 1993-09-30
GR3035479T3 (en) 2001-05-31
FI931250A0 (fi) 1993-03-22
RU2129545C1 (ru) 1999-04-27
HUT69685A (en) 1995-09-28
KR930019630A (ko) 1993-10-18
NO931056L (no) 1993-09-27
PT562512E (pt) 2001-06-29
SK280884B6 (sk) 2000-09-12
HU219224B (en) 2001-03-28
SK22393A3 (en) 1993-10-06
HK1011987A1 (en) 1999-07-23
NO179867B (no) 1996-09-23
CN1076691A (zh) 1993-09-29
CZ46393A3 (en) 1994-01-19
FI931250A (fi) 1993-09-25
HU9300850D0 (en) 1993-06-28
ATE199250T1 (de) 2001-03-15
TW352384B (en) 1999-02-11
HU210714A9 (en) 1995-06-28
PL173677B1 (pl) 1998-04-30
DE59310146D1 (de) 2001-03-29
NO179867C (no) 1997-01-02
NZ247201A (en) 1996-05-28
EP0562512A1 (de) 1993-09-29
ES2154266T3 (es) 2001-04-01
AU657608B2 (en) 1995-03-16
PL298195A1 (en) 1994-01-10
DK0562512T3 (da) 2001-03-19
CA2092276A1 (en) 1993-09-25
EP0562512B1 (de) 2001-02-21
US5607954A (en) 1997-03-04
FI102895B (sv) 1999-03-15

Similar Documents

Publication Publication Date Title
FI102895B1 (sv) Förfarande för framställning av terapeutiskt aktiva 5-(fenylsulfonylamino)- och 5-(fenylsulfonylaminokarbonyl)pyridin-2-karboxylsyraamider
ES8609251A1 (es) Un procedimiento para preparar un compuesto de n-aril-n- -(4-piperidinil)-alcoxialquilamida
ES2113413T3 (es) Derivados antiviricos del acido 2-desoxi-2,3-didehidro alfa-d-neuraminico 4 substituido.
ES2102132T3 (es) Amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
ES2052065T3 (es) Formulacion dispersable.
DK0612731T3 (da) Nye quinolon- og naphthyridoncarboxylsyrederivater
TNSN89016A1 (fr) Procede pour la preparation d'esters d'acide cepheme - carboxylique
EP0457090A3 (en) Process for the preparation of 3-amino-2 (het)aroyl-acrylic acid derivatives
ES2054089T3 (es) Formulaciones orales liquidas.
FI934303A0 (fi) Acylsulfonamido- och sulfonamidopyridin-2-karboxylsyraestrar och deraspyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
SE8503109L (sv) Cykliska forstadielekemedel till antiinflammatoriska oxikamer
DE59307401D1 (de) Alpha-Aryl-alpha-hydroxy-beta-imidazolinylpropionsäureamide
GR3015937T3 (en) Salts of the 2-(2,6-dichloroanilino)-phenylacetic acid, process for their preparation and their application as pharmaceutical preparations for topical use.
IT1241515B (it) Sali dell'acido nicotinico con composti aminobenzilici e loro impiego farmaceutico".
IT8021053A0 (it) Ammidi dell'acido teofillin-7-acetico, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
IT8948511A0 (it) Nuovi sali dell'acido nicotinico con composti aminobenzilici e loro impiego farmaceutico.
IT8221556A0 (it) Ammidi dell'acido teofillin-7-acetico, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
IT7827749A0 (it) Ammidi dell'acido di-tio-salicilico alchilate basiche, procedimento per la loro preparazione e loro impiego come prodotti medicinali.
DE69325531T2 (de) Oral anzuwendendes Arzneimittel bestehend aus Ibuprofen